Nicotine mini 4 mg/1 (Nicotine Polacrilex LOZENGE) 4 mg/1

Nicotine mini 4 mg/1 lozenges are a smoking cessation aid designed to help reduce nicotine cravings. These oral lozenges provide a controlled release of nicotine to support quitting smoking.

Strength

4 mg/1

Pack Size

5 CONTAINER in 1 CARTON (0363-0957-04) / 27 LOZENGE in 1 CONTAINER

Manufacturer / TM Owner

Walgreen Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nicotine mini 4 mg/1 lozenges are used as a smoking cessation aid. They help manage nicotine cravings and withdrawal symptoms by delivering nicotine through the oral mucosa. This can be part of a broader strategy to quit smoking, often used in conjunction with behavioral support.

Side Effects

Nicotine mini 4 mg/1 lozenges work by releasing nicotine into the body, which can help alleviate withdrawal symptoms experienced when quitting smoking. Users may feel a reduction in cravings and an improvement in focus and mood as the nicotine is absorbed.

Precautions & Warnings

Nicotine mini 4 mg/1 lozenges should be used with caution, especially by individuals with certain medical conditions such as heart disease or high blood pressure. It is important to follow the recommended usage guidelines and consult a healthcare provider if you have any concerns.

Avoid Interactions

Nicotine mini 4 mg/1 lozenges may interact with certain medications, including those metabolized by the liver's cytochrome P450 enzymes. Additionally, using nicotine products in combination with other nicotine-containing products or smoking can increase the risk of nicotine overdose.

Frequently Asked Questions

Nicotine mini 4 mg/1 lozenges are used to help manage nicotine cravings and withdrawal symptoms as part of a smoking cessation program.

These lozenges release nicotine through the oral mucosa, which is then absorbed into the body to help reduce cravings and withdrawal symptoms.

It is important to consult a healthcare provider before using Nicotine mini 4 mg/1 lozenges with other medications, as interactions may occur.

Common effects include a reduction in nicotine cravings and withdrawal symptoms, as well as potential improvements in focus and mood.

Yes, individuals with certain medical conditions such as heart disease or high blood pressure should use these lozenges with caution and consult a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.